These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17487728)

  • 21. Immunomodulating drugs for chronic lymphocytic leukaemia.
    Chanan-Khan A; Porter CW
    Lancet Oncol; 2006 Jun; 7(6):480-8. PubMed ID: 16750498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of lenalidomide in relapsed/refractory chronic lymphocytic leukemia patient: a systematic review and meta-analysis.
    Liang L; Zhao M; Zhu YC; Hu X; Yang LP; Liu H
    Ann Hematol; 2016 Sep; 95(9):1473-82. PubMed ID: 27329288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study.
    Chang JE; Havighurst T; Kim K; Eickhoff J; Traynor AM; Kirby-Slimp R; Volk LM; Werndli J; Go RS; Weiss M; Blank J; Kahl BS
    Br J Haematol; 2016 Apr; 173(2):283-91. PubMed ID: 26913697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia.
    Riches JC; Gribben JG
    Curr Cancer Drug Targets; 2016; 16(8):689-700. PubMed ID: 27055579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-agent lenalidomide in the treatment of previously untreated chronic lymphocytic leukemia.
    Chen CI; Bergsagel PL; Paul H; Xu W; Lau A; Dave N; Kukreti V; Wei E; Leung-Hagesteijn C; Li ZH; Brandwein J; Pantoja M; Johnston J; Gibson S; Hernandez T; Spaner D; Trudel S
    J Clin Oncol; 2011 Mar; 29(9):1175-81. PubMed ID: 21189385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia.
    Lee BN; Gao H; Cohen EN; Badoux X; Wierda WG; Estrov Z; Faderl SH; Keating MJ; Ferrajoli A; Reuben JM
    Cancer; 2011 Sep; 117(17):3999-4008. PubMed ID: 21858802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lenalidomide: immunomodulatory, antiangiogenic, and clinical activity in solid tumors.
    Dreicer R
    Curr Oncol Rep; 2007 Mar; 9(2):120-3. PubMed ID: 17288877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Costa LJ; Fanning SR; Stephenson J; Afrin LB; Kistner-Griffin E; Bentz TA; Stuart RK
    Leuk Lymphoma; 2015 Mar; 56(3):645-9. PubMed ID: 25130476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial.
    Mauro FR; Carella AM; Molica S; Paoloni F; Liberati AM; Zaja F; Belsito V; Cortellezzi A; Rizzi R; Tosi P; Spriano M; Ferretti A; Nanni M; Marinelli M; De Propris MS; Orlando SM; Vignetti M; Cuneo A; Guarini AR; Foà R
    Leuk Lymphoma; 2017 Jul; 58(7):1640-1647. PubMed ID: 27881039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lenalidomide for the treatment of B-cell malignancies.
    Chanan-Khan AA; Cheson BD
    J Clin Oncol; 2008 Mar; 26(9):1544-52. PubMed ID: 18285605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lenalidomide can be highly effective in chronic lymphocytic leukaemia despite T-cell depletion and deletion of chromosome 17p.
    Arumainathan A; Kalakonda N; Pettitt AR
    Eur J Haematol; 2011 Oct; 87(4):372-5. PubMed ID: 21679253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide.
    Srinivasan S; Schiffer CA
    Leuk Res; 2009 Apr; 33(4):561-4. PubMed ID: 18676017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia.
    Maffei R; Fiorcari S; Bulgarelli J; Rizzotto L; Martinelli S; Rigolin GM; Debbia G; Castelli I; Bonacorsi G; Santachiara R; Forconi F; Rossi D; Laurenti L; Palumbo GA; Vallisa D; Cuneo A; Gaidano G; Luppi M; Marasca R
    Exp Hematol; 2014 Feb; 42(2):126-36.e1. PubMed ID: 24212063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lenalidomide - current understanding of mechanistic properties.
    Tageja N
    Anticancer Agents Med Chem; 2011 Mar; 11(3):315-26. PubMed ID: 21426296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner.
    Masood A; Chitta K; Paulus A; Khan AN; Sher T; Ersing N; Miller KC; Manfredi D; Ailawadhi S; Borrelo I; Lee KP; Chanan-Khan A
    Br J Haematol; 2012 Apr; 157(1):59-66. PubMed ID: 22171982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lenalidomide mode of action: linking bench and clinical findings.
    Davies F; Baz R
    Blood Rev; 2010 Nov; 24 Suppl 1():S13-9. PubMed ID: 21126632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies.
    Morgan G
    Blood Rev; 2010 Nov; 24 Suppl 1():S27-32. PubMed ID: 21126634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The application and biology of immunomodulatory drugs (IMiDs) in cancer.
    Pan B; Lentzsch S
    Pharmacol Ther; 2012 Oct; 136(1):56-68. PubMed ID: 22796518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lenalidomide as first-line therapy for elderly CLL patients.
    Gilbert JA
    Lancet Oncol; 2013 Aug; 14(9):e345. PubMed ID: 24058966
    [No Abstract]   [Full Text] [Related]  

  • 40. New agents in chronic lymphocytic leukemia.
    Lin TS
    Curr Hematol Malig Rep; 2010 Jan; 5(1):29-34. PubMed ID: 20425394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.